Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
11/2003
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095444A1 Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
11/06/2003US20030207788 1,2 Substituted 2,3-dihydro- 1H-5,9 dioxacyclohepta[F]indden-7-ones and 7-substituted benzo[B][1,4]dioxepin-3 ones
11/06/2003US20030207329 1, 2-Dioxetane derivatives and reagents employing them
10/2003
10/28/2003US6638979 Imidamide derivatives
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003US20030199553 Antidiabetic agents
10/22/2003CN1450064A 5-benzamido-1,3-dioxide cyclo group compound and preparation process thereof, and use in preparing protein kinase C inhibito medicine
10/16/2003WO2003041643A3 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/09/2003WO2003082851A1 Ether lactone
10/08/2003EP1220850B1 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
10/08/2003EP0898557B9 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
09/2003
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181736 Diphosphines
09/24/2003CN1443762A Method for synthesizing aromatic cyclic oligomer
09/18/2003US20030175838 Comprises dioxetane compound and phosphatases
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1342724A1 1,2-dioxetane derivates and reagents employing them
09/10/2003EP1341798A1 Chiral diphosphines and their metal complexes
09/10/2003EP1341742A1 Method for producing compounds having a cf2o bridge
09/04/2003WO2003072570A1 Antidiabetic agents
09/03/2003EP1340500A1 Antidiabetic agents
08/2003
08/28/2003WO2003070714A1 Fluorous acetylation
08/28/2003CA2419685A1 Antidiabetic agents
08/26/2003US6610216 Multicolor photopolymerizable compound
08/19/2003CA2043733C Aromatic compounds
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/07/2003US20030145641 Fertilization mixture containing pyrazole compound
08/05/2003US6602901 Antidiabetic agents, obesity
07/2003
07/31/2003WO2003062253A1 Metal complexes for use in metathesis
07/31/2003CA2473029A1 Ruthenium and osmium carbene complexes for use in metathesis
07/30/2003CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid
07/24/2003US20030139610 Washing the aqueous plant extract with a solvent, adjusting the pH from 10 to less 9, solvent extration of flavonoids
07/22/2003US6596903 Ring opening 4-(2-amino-1-hydroxyethyl)oxazoline by reaction with organic mercaptan; stereospecific; human immunodeficiency virus protease inhibitors
07/16/2003EP1326855A1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
07/16/2003EP1326854A1 Chiral binaphthol derivatives
07/09/2003EP1325054A1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
07/09/2003CN1113878C Method of purifying macrocyclic ester compound of musk
07/03/2003WO2003054506A2 Deuterium-based chemiluminescent 1,2-dioxetanes
07/03/2003WO2003010116A3 Process for isolating phenolic compounds
06/2003
06/25/2003CN1426384A Method for producing ketal and/or acetal
06/17/2003CA2110045C Hydroxy containing fluorovinyl compounds and polymers thereof
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/04/2003EP1315713A2 Method for the production of macrocyclic esters
06/04/2003CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same
06/03/2003US6573391 1,4-Dioxacylcloalkane-2-one and 1,4-dioxacycloalkene-2-one
05/2003
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041643A2 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/20/2003US6566298 Diphosphines
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/07/2003CN1415611A Method for preparing muskiness compound of macrolide class
05/07/2003CN1415610A Technique for producing compound of macrolide
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
04/2003
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/23/2003EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation
04/23/2003EP0898557B1 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
04/17/2003US20030073680 Therapy for Tay-sach, Gaucher diseases
04/16/2003EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
03/2003
03/06/2003US20030045713 Diphosphines
03/05/2003CN1102591C Process for purifying and repining macrocyclic diester musk compounds
02/2003
02/27/2003US20030040633 Useful for therapy of HIV-related diseases based on its inhibitory action on proteases derived from viruses
02/27/2003US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation
02/25/2003US6525197 Producing chemical intermediates for such as epothilone or epothilone analogues synthesis
02/25/2003US6525086 Compounds, their preparation and use
02/12/2003EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use
02/06/2003WO2003010157A1 Dioxane derivatives and a process for their preparation
02/06/2003WO2003010116A2 Process for isolating phenolic compounds
02/06/2003CA2454636A1 Process for isolating phenolic compounds
02/04/2003US6514717 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
01/2003
01/29/2003CN1100055C Piperazine and piperidine compounds
01/23/2003WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/22/2003CN1392147A Aromatic cyclic polyketone oligomer and its preparing method
01/16/2003WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists
01/14/2003US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation
01/09/2003US20030006398 Optically active compound, photoreactive chiral agent, liquid crystal composition, method for changing helical structure of liquid crystal, method for fixing helical structure of liquid crystal, liquid crystal color filter, optical film, and recording medium
01/07/2003US6504035 3-deoxy-desmycosin derivatives and process for their preparation
12/2002
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/04/2002EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
12/03/2002US6488734 Nitrification inhibitors, and the use of polyacids which contain a nitrification inhibitor for the treatment of inorganic fertilizers
11/2002
11/28/2002WO2002094805A1 Chiral compounds
11/19/2002US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/06/2002EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/05/2002US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002US6476232 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same
10/2002
10/17/2002WO2001057015A9 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION
10/09/2002EP0975622B1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
10/08/2002US6462200 Diphosphines
10/03/2002WO2000044719A3 1,2-dioxetanes, preparation and use thereof for the dosing of thiols and acetylcholinesterase
10/01/2002US6458972 Process for the preparation of macrocyclic esters
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
09/2002
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/25/2002EP0794987B1 Chemiluminescent dialkyl-substituted 1,2-dioxetane compounds, methods of synthesis and use
09/18/2002EP0823889B1 1,3-propane diol derivatives as bioactive compounds
09/17/2002US6451531 Dioxetane labeled probes and detection assays employing the same
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 21